The Hottest Healthcare Services Verticals for Private Equity in 2025
Behavioral Health, Infusion, and Staffing firms top the list in BRG’s survey
Many lower middle market private equity groups have revisited their investment... Read more.
Momentum Builds for Ophthalmology Recapitalizations
McKesson’s acquisition of PRISM Vision Group is an important milestone for private equity’s investments in ophthalmology practices.
McKesson Corporation’s... Read more.
2025 Could Be the Year of the Retina Practice Deal
2025 Could Be the Year of the Retina Practice Deal
Momentum is building around retina practice transactions following Cencora’s November announcement that... Read more.
FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy
FOCUS Investment Banking Represents Mid-Michigan ENT in its Partnership with Align ENT + Allergy
Washington, DC, (September 27, 2024) – FOCUS Investment... Read more.
FOCUS Investment Banking Represents Dulles Eye Associates in its Partnership with ReFocus Eye Health
FOCUS Investment Banking Represents Dulles Eye Associates in its Partnership with ReFocus Eye Health
Washington, DC, (September 27, 2024) – FOCUS Investment... Read more.
ENT & Allergy – 2024 Update: Conservative Pace Continues
ENT & Allergy – 2024 Update: Conservative Pace Continues
Summary
Private equity-backed Physician Practice Management (“PPM”) companies in the... Read more.
Ophthalmology – 2024 Update: Entering a Mature Stage
Ophthalmology – 2024 Update: Entering a Mature Stage
Summary
Private equity’s investments in ophthalmology are entering a new, more mature lifecycle... Read more.
Ophthalmology 2024 Update
Ophthalmology 2024 Update
Private equity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We expect continued transaction... Read more.
FOCUS Investment Banking Represents Michigan ENT and Allergy Specialists in its Partnership with Parallel ENT and Allergy
FOCUS Investment Banking Represents Michigan ENT and Allergy Specialists in its Partnership with Parallel ENT and Allergy
Washington, DC, (November 30, 2023)... Read more.
How to Manage Risks When Selling Your Physician Practice
How to Manage Risks When Selling Your Physician Practice
Based on the large number of medical practices acquired over the past decade, you may think selling... Read more.
How to Value a Medical Practice: What Really Matters
How to Value a Medical Practice: What Really Matters
This article focuses on how medical practices are valued by private equity-backed groups, and to an extent,... Read more.
FOCUS Investment Banking Represents CORE Industrial Partners in its Acquisition of Coining Manufacturing and Precision Machine Products
FOCUS Investment Banking Represents CORE Industrial Partners in its Acquisition of Coining Manufacturing and Precision Machine Products
Washington, DC, (July... Read more.
ENT & Allergy Practices Attract Private Equity
ENT & Allergy Practices Attract Private Equity
Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted... Read more.
FOCUS Investment Banking Represents East Coast Retina, PA in its Sale to Retina Consultants of America
FOCUS Investment Banking Represents East Coast Retina, PA in its Sale to Retina Consultants of America
Washington, DC, (June 20, 2023) – FOCUS Investment... Read more.
Private Equity Interest in Orthopedics Grows
Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. But that’s been... Read more.